体重指数、体重减轻与超重或肥胖的多囊卵巢综合征女性妊娠机会之间的关联:英国回顾性队列研究
该回顾性队列研究利用英国临床实践研究数据链GOLD数据库,纳入多囊卵巢综合征(PCOS)女性,分析基线体重指数(BMI)与体重变化对妊娠机会的影响。结果显示,基线BMI越高妊娠机会越低;体重减轻与妊娠机会增加相关,而维持稳定体重或增重则无此关联。
要点
- PCOS女性基线BMI越高,3年内妊娠机会越低。
- 体重减轻与妊娠机会增加相关,而维持稳定或增重则无此关联。
- 该研究为观察性回顾性队列,结果需结合原文局限性解读。
核心结论
- 在PCOS女性中,较高的基线BMI与较低的妊娠机会相关;体重减轻与妊娠机会增加相关,而维持稳定体重或增重则无此关联。
研究设计与样本
- 回顾性队列研究,数据来自英国临床实践研究数据链GOLD数据库,纳入年龄18-45岁、PCOS诊断时BMI≥18.5 kg/m2(研究1)或≥25 kg/m2(研究2)的女性,主要结局为36个月随访期间首次妊娠时间,采用Cox比例风险模型分析并以风险比(HR)呈现。
- 研究1纳入9955例PCOS女性;研究2纳入7593例PCOS女性,中位BMI为34.0 kg/m2。
主要发现
- 诊断后3年内,较高BMI与较低妊娠机会相关;正常体重(18.5-24.9 kg/m2)女性中估计41%会妊娠,而肥胖III级(BMI≥40.0 kg/m2)女性中为17%。
- 在相同年龄和血糖状态下,肥胖III级女性的妊娠机会估计比正常体重女性低63%(HR 0.37,95%CI 0.31-0.44;P<0.0001)。
- BMI变化与妊娠机会呈显著负相关:基线BMI为40 kg/m2的女性,体重减轻10%估计使妊娠机会增加68%(HR 1.68,95%CI 1.49-1.90)。
临床怎么用
- 作者的观察为进一步支持超重/肥胖且PCOS、有妊娠意愿的女性减轻体重提供了证据。
局限性
- 多种因素影响妊娠机会(妊娠能力和意愿),已通过排除标准处理。
- 研究的真实世界性质意味着无法获取非处方避孕药具使用情况。
- CPRD GOLD数据库中仅约40%的PCOS女性在PCOS诊断前一年记录了BMI,可能引入偏倚。
- 分析中使用的BMI分类可能不适用于所有种族的女性。
- 研究人群仅代表英国女性,结果可能无法推广至其他地区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the associations between baseline BMI (Study 1) and change in body weight (Study 2) with the likelihood of pregnancy in women with polycystic ovary syndrome (PCOS). SUMMARY ANSWER: In women with PCOS, higher baseline BMI was associated with a lower chance of pregnancy; however, weight loss was associated with an increased chance of pregnancy versus maintaining a stable weight or gaining weight. WHAT IS KNOWN ALREADY: Two studies in large cohorts of Danish women with the intention to become pregnant showed a decline in fecundability ratios with higher BMI. Furthermore, a meta-analysis found that overweight/obesity significantly worsened metabolic and reproductive outcomes in women with PCOS. STUDY DESIGN, SIZE, DURATION: Data were extracted from the UK Clinical Practice Research Datalink GOLD database. Patients included women aged 18-45 years with BMI ≥18.5 (Study 1) or ≥25 kg/m2 (Study 2) at time of PCOS diagnosis (index date). The primary outcome was the time to first pregnancy recorded during 36-months' follow-up, analysed with Cox proportional hazard models and presented as hazard ratios (HRs). PARTICIPANTS/MATERIALS, SETTING, METHODS: Study 1 included 9955 women with PCOS. Study 2 included 7593 women with PCOS and median BMI of 34.0 kg/m2. MAIN RESULTS AND THE ROLE OF CHANCE: Higher BMI was associated with a lower chance of pregnancy in the 3 years following diagnosis. It was estimated that 41% of women with normal weight (18.5-24.9 kg/m2) would become pregnant compared to 17% of women with obesity class III (BMI ≥40.0 kg/m2) during follow-up. Furthermore, the chance of pregnancy for women with obesity class III was estimated to be 63% lower than for women with normal weight, with the same age and glycaemic status (HR 0.37, 95% CI 0.31-0.44; P < 0.0001). A significant inverse association was found between BMI change and chance of pregnancy: 10% weight loss was estimated to increase the chance of pregnancy by 68% for women with baseline BMI of 40 kg/m2 (HR 1.68, 95% CI 1.49-1.90). LIMITATIONS, REASONS FOR CAUTION: Multiple factors influence the chance of pregnancy (the ability and willingness to become pregnant), which was addressed by exclusion criteria employed. The real-world nature of the study means that use of non-prescription contraceptives was not available. Bias may have been introduced by the fact that only around 40% of women with PCOS in the CPRD GOLD database had their BMI recorded during the year prior to PCOS diagnosis. BMI categories used in the analyses may not be applicable to women of all ethnicities. The study population was only representative of women in the UK and results may not be generalizable to other regions. PCOS diagnoses were based on codes entered into the system by primary care providers, and no information was available regarding the criteria used for diagnosis, although symptoms used to diagnose PCOS have not changed over time. WIDER IMPLICATIONS OF THE FINDINGS: Our observations provide further evidence of the benefits of weight loss in women with overweight/obesity and PCOS who are seeking to become pregnant. STUDY FUNDING/COMPETING INTEREST(S): Novo Nordisk A/S. A.H.B. declares fees for consultancy from Novo Nordisk. P.N.L. and C.L.H. are employees of Novo Nordisk. V.S. and A.V. are employees of, and hold shares in, Novo Nordisk. TRIAL REGISTRATION NUMBER: N/A.
引用
- Haase CL, Varbo A, Laursen PN, et al. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK. Hum Reprod. 2023. PMID: 36637246. doi:10.1093/humrep/deac267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。